Search
for
Sort by
Research 571–600 of 715
- Alopecia Areata
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Early stage alopecia areata is associated with inflammation in the upper dermis and damage to the hair follicle infundibulum
- Treatment of Severe Alopecia Areata: Combination Therapy Using Systemic Cyclosporine A with Low Dose Corticosteroids
- Awareness, Beliefs, and Psychological Impact of Patients with Alopecia Areata in Saudi Arabia: A Multi-Center Study
- Reply to ‘Frontal fibrosing alopecia’
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- THE WONDER OF HERBS TO TREAT–ALOPECIA
- Immunization and Bacterial Pathogens in the Oropharynx as Risk Factors for Alopecia Areata
- Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata
- Serum levels of ifn-γ, complement component c3 c4 and vitamin d3 in the prognosis of patients with alopecia areata prospective teachers
- Alopecia areata in Black African patients: epidemiological, clinical, and therapeutic aspects
- Increase in IL-15 levels in patients with alopecia areata
- The demographic and clinical profile of patients with alopecia areata in Syria: A study letter
- Quality of Life in Patients with Alopecia Areata presenting to the Department of Dermatology at a Tertiary Care Hospital of Lahore, Pakistan
- New therapies for alopecia areata
- Associated comorbidities in pediatric patients with alopecia areata
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Association of Serum IL-17A and IL-23 Levels With Alopecia Areata: A Cross-Sectional Comparative Study
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- Epidemiology of alopecia areata and its association with atopic dermatitis: A comparative analysis of data from the Moscow Center of Dermatovenereology and Cosmetology and the Federal Registry
- Treatment outcomes and considerations for topical immunotherapy in patients with alopecia totalis and alopecia universalis
- Consider Cultural Practices and Barriers to Care When Treating Alopecia Areata
- Journal of Population Therapeutics and Clinical Pharmacology
- Ritlecitinib in severe alopecia areata: a profile of its use
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Efficacy of modern methods for assessing the severity of alopecia areata
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Topical sodium valproate-loaded nanospanlastics versus conventional topical steroid therapy in alopecia areata: a randomized controlled study
- Factors Affecting the Response and Patient Satisfaction of Topical Immunotherapy in Alopecia Areata: A Nationwide Study